home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops
Search
 
 

Biosimilars: Where Are We Now and Where Are We Headed

  
  December 21, 2016
Pharma Development and Business
  
     
 
CfPA-The Center for Professional Advancement, 90 Minute Accredited Online Training
January 25, 2017 at 11:00 a.m.–12:30 p.m. (ET)

Who Should Attend?
This online training will benefit professionals in the following industries:
  • Pharmaceutical
  • Medical Device
  • Biotechnology
  • Scientific Instruments

It is especially valuable to:
  • Scientists
  • Quality/Regulatory personnel
  • Patent Attorneys
  • Health Care Strategy Maker

This training will be worthwhile to professionals working in the following departments:
  • Research and Development
  • Manufacturing
  • QA/QC, Regulatory
  • Legal
  • Clinical 

Course Description
A brief journey from the early history of Biosimilar to its current status of challenges and limitations will be discussed. After taking this course you will have a clear idea of significance of this important segment of pharmaceutical health care. There will be a critical discussion about where we can expect it to go in the near future.

Can't Make this LIVE Webinar? 
Simply select the On Demand option when registering and we will send you the link to view the recorded version.

This course will be available On Demand: January 26, 2017
  
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
Raghvendra Sahai Ph.D.; President and CEO of EuTech Scientific Services, Inc.

Dr. Raghvendra Sahai is founder of EuTech Scientific Services, Inc. a 22 year old Analytical chemistry Research based Contract Research Organization. Dr. Sahai has been involved in the complete chemical characterization of large biomolecules with his team for submission to regulatory agencies. Dr. Sahai has successfully lead the company for FDA GMP approval for testing some biological drugs for his client companies. He has founded another successful company in scientific consumable area and acquired another research based testing laboratory in his business career.
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: jmorbit@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.